In kidney disease, blocking PI3Kγ signaling pathway in Ang-II-induced kidney damage could alleviate renal injury and fibrosis, and thus improve renal functions, as well as be investigated as a fresh therapeutic method for the treatment of renal fibrosis, renal hypertension, and CKD [61]. Here, AGT is linked to chronic kidney disease.